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Three 3H peaks were eluted at 0, 0.15 and 0.45M-NaC1 concentrations corresponding to neutral (1) and acidic glycoproteins (2) and proteoglycans (3) respectively. Peak (3) was labelled with [35S]SOi-and 3H and contained about 90% proteoheparan sulphate. The release of glycoproteins and proteoglycans by the cells increased with progressing number of subcultures. The label in the acidic glycoproteins and in the proteoglycans, as well as the ratio of proteoheparan sulphate to glycoproteins, decreased in the presence of eye-derived growth factor (Table 1) .
When cells were detached by Triton X-100,3-5% of the label of the matrix were associated with the removed cells. This cell-associated radioactivity decreased in the late subcultures in the acidic glycoproteins and proteoglycans, and in the presence of the growth factor.
These findings suggest that cells from late subcultures degrade more of the matrix components than cells from early passages, but the former incorporate less degraded material (Table 1) . It seems that the eye-derived growth factor affects the synthesis (Moczar et al., 1983) and also the degradation of the macromolecular glycoconjugates of the subendothelial matrix. Oligosaccharide structures containing the groupings NeuAca2-3Galfll-4 [ Fuca 1-31 GlcNAc and NeuAca2-3Galp 1-3 ClcNAc occur in glycoconjugates in human secretions and on cell surfaces in both normal and tumour tissues (Rauvala, 1976; Magnani et al., 1982; Fukushima et al., 1984; Hanisch et al., 1984) . Until now the pathways of biosynthesis of these structures have been unclear. The a-3/4-~-fucosyltransferase purified from human milk was reported not to utilize 3'-sialyl-lactose (NeuAca2-3GalflI-4Glc), or glycoproteins containing a2-3-linked sialic acid as acceptor substrates (Prieels et al., 1981, 19831 , a result implying either that a different a-3-~-fucosyltransferase is involved in the formation of the sialylfucosyl structure or that the order of synthesis is first the formation of the a-3-L-fucosyl linkage and secondly the addition of the sialyl residue. The aim of the present work was t o examine the role of sialyl-containing oligosaccharides and glycoproteins as acceptor substrates for two purified human a-3-L-fucosyltransferases, namely the a-3-~-fucosyltransferase from plasma that catalyses the transfer of L-fucose to internal N-acetyl-D-glucosamine residues (SchenkelBrunner et al., 1972) and the Lewis (Le) blood group gene-dependent a-3/4-L-fucosyltransferase that occurs in epithelial secretions and utilizes both N-acetyl-D-glucosamine and D-glucose residues in acceptor substrates (Johnson et al., 1981) .
A preparation of a-3/4-~-fucosyltransferase purified 300 000-fold was isolated from human milk by a succession of steps involving ammonium sulphate precipitation followed by chromatography on phenyl-Sepharose CL4B, CM-Sepharose and GDP-hexanolamine-Sepharose. a -3 -~-Fucosyltransferase from human serum was purified 600 000-fold by steps involving ammonium sulphate precipitation and chromatography on phenyl-Sepharose CL-4B and GDPadipate-Sepharose. The acceptor substrate specificities of the purified enzymes were tested with a range of low-M, acceptors and with glycoproteins before and after the removal of sialic acid. The a-3/4-L-fucosyltransferase from human milk transferred fucose from GDP-fucose to both 3'-sialyl-lactosamine (NeuAca2-3Gal/31-4GlcNAc) and 3'-sialyl-lacfiose but neither 6'-sialyl-lactosamine (NeuAca2-6Galfl1-4GlcNAc) nor 6'-sialyl-lacfose (NeuAca2-6Gal/31-4Glc) functioned as acceptors. 3 -Sialyl-lactosamine was Table 1 . Vol. 13
BIOCHEMICAL SOCIETY TRANSACTIONS also a good acceptor for the a-3-~-fucosyltransferase from human serum, although, in keeping with the 1yw affinity of this enzyme for lactose, the corresponding 3 -sialyl-lactose was a poor substrate (Table 1) . The fucosyl products formed with 3'-sialyl-lactosamine were characterized by their chromatographic mobilities and response t o exoglycosidases. Treatment with Vibrio cholerae neuraminidase gave a product that co-chromatographed with authentic Galpl-4[Fucal-3] ClcNAc. Before neuraminidase treatment the fucosyl product was not cleaved by either an 01-2-or a-3/4-~-fucosidase from Trichomonas foetus (Stealey & Watkins, 1971 ) but after removal of sialic acid the fucose was specifically removed by the a-3/4-~-fucosidase. Transferrin, a,-acid glycoprotein, fetuin, and a blood group precursor glycoprotein isolated from ovarian cyst fluid were each acceptors for both the a-3-and the a-3/4-L-fucosyltransferases. Removal of the sialic acid from transferrin and from the precursor glycoprotein resulted in a marked increase in the incorporation of L-fucose, whereas removal of sialic acid from fetuin or a,-acid glycoprotein brought about only marginal changes in the levels of incorporation.
These results demonstrate that both the a-3-L-fucosyltransferase from human plasma and the Lewis gene-dependent a-3/4-L-fucosyltransferase from human milk catalyse the transfer of L-fucose from GDP-L-fucose to NeuAca2-3Galfll-4GlcNAc and to sialic acid-containing glycoproteins. Hence it is reasonable t o assume that the biosynthetic pathway for the formation of GlcNAc proceeds via the transfer of a-3-linked L-fucose to the preformed sialylated structure. Likewise, since the a-3/4-L-fucosyltransferase catalyses the addition of L-fucose to both the 0-3 and 0 -4 positions of subterminal N-acetyl-D-glucosamine residues, it is to be anticipated that this enzyme also catalyses the formation of NeuAccr2-3Galpl-3 [Fuc~-l-4]GlcNAc (sialylated Lewisa determinant) from NeuAca2-3Galp 1 -3GlcNAc.
In recent years interest has arisen in the alterations of gastric mucus glycoproteins in gastric carcinoma, particularly concerning those changes which may occur in the oligosaccharide units. Immunological (Picard & Feizi, 1984) , histochemical staining (Jass & Filipe, 1979) and lectin histochemical studies (Fischer et al., 1984) have indicated that the oligosaccharide units may be altered in gastric t umour tissue.
The 0-linked oligosaccharides obtained from gastric aspirates or gastric mucosa consist of up to 15 monosaccharide residues with a common basic composition (Oates et al., 1974; Schrager & Oates, 1974) . Recently, the structures of a number of neutral oligosaccharides from gastric aspirates have been elucidated (Slomiany et al., 19844b) . However, a recognized problem with aspirates is contamination with salivary and bronchial mucus (Oates et al., 1974) . In addition, the oligosaccharide alterations that have been identified occur within the mucosa.
In this study the greater accessibility of formalin-fixed gastric tissue with known histological assessment was exploited as a source of mucus glycoproteins. These glycoproteins and their oligosaccharide units are compared with those derived from whole human gastric mucus.
Formalin-fixed stomachs were sectioned into normal or tumour areas for antrum and body regions. The mucosal layer was homogenized in phosphate-buffered saline (5ml/g $ To whom correspondence should be addressed.
of tissue) and centrifuged (1OOOOOg for 30 min). Whole human gastric mucus obtained from macroscopically normal stomachs within 30 min of surgery was homogenized in 50 mM-potassium phosphate, pH 7.4, and centrifuged (23 500g for 15 min). Soluble material from both sources was dialysed against water and freeze-dried before pronase digestion (2 x 2.5 mg of pronase/lOO mg of material, added at 24 h intervals) in 20mM-CaClz, pH 7.4 (25 mg of material/ml), at 37°C for 48 h. After dialysis, the proteolysis was repeated. The supernatant after centrifugation at 39000g for 25min was freeze-dried. The mucus glycoproteins ( K , < 0.5) were separated from glycopeptides and peptides by gel filtration on a column (52 cm x 2.6 cm) of Sephacryl S-400 eluted with 0.2M-NaC1.
Mucus glycoprotein (0.3-2.0 mg) was subjected t o alkaline borohydride elimination and reduction essentially by the method of Iyer & Carlson (1 97 1) using 0.1 M-NaB3H4 (sp. activity 42mCi/mmol) in 50mM-NaOH for 16 h at 50°C.
incorporation by mucus glycoproteins derived from formalin-fixed tissue (3.4 x lo7 d.p.m./mg of glycoprotein) was similar to that for mucus glycoproteins purified from whole mucus (3.7 x lo7 d.p.m./mg). There was no significant difference in the incorporation by glycoproteins from tumour or normal tissue derived from the body region of the stomach. This may indicate that the density and distribution of oligosaccharide units is not altered in body tumours. In contrast, significantly less 3H was incorporated into the glycoproteins from antral tumours (2.5 x lo7 d.p.m./mg) compared with the normal tissue (3.8 x lo7 d.p.m./mg) from this region, possibly indicating fewer oligosaccharide units.
The 3H-labelled oligosaccharide alditols were chromatographed on a column (131 cm x 1.1 cm) of Biogel P6
